Views & Analysis Why should pharma invest in digital products for those livin... Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges.
News Data privacy concerns don't hinder digital health app usage A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on
Views & Analysis Managing chronic illness in children and adolescents With up to a quarter of US children and adolescents affected by a chronic condition, Sinead Ni Mhurchadha and Anna O’Sullivan stress the importance of understanding their needs and developing t
Views & Analysis Patient-centricity and long-term conditions – where next? Comprehensive guidance, education and training are vital to upskill clinicians and others in patient-centred healthcare.
Views & Analysis Addressing the challenges of chronic disease Technology will play a big part in management of people with long-term conditions.
News Incyte blocks US launch of Sun Pharma's alopecia drug A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.